The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 7, 2003, Pages 3368-3371

  Marini, Maria Adelaide ^a   Frontoni, Simona ^a   Mineo, Davide ^a   Bracaglia, Daniela ^a   Cardellini, Marina ^a   De Nicolais, Pierluigi ^b   Baroni, Alessandra ^a   D'Alfonso, Rossella ^a   Perna, Michela ^a   Lauro, Davide ^a   Federici, Massimo ^a   Gambardella, Sergio ^a   Lauro, Renato ^a   Sesti, Giorgio ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; PHOSPHOPROTEIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROGENY; PROTEIN VARIANT; RISK FACTOR; FAMILY HEALTH; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; MIDDLE AGED; PARENT; POINT MUTATION;

ADULT; DIABETES MELLITUS, TYPE 2; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PARENTS; PHOSPHOPROTEINS; POINT MUTATION; RISK FACTORS; VARIATION (GENETICS);

EID: 0037622751     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021716     Document Type: Article

References (27)

1. Reaven GM 1988 Role of insulin resistance in human disease. Diabetes 37: 1595-1607
2. Hong Y, Pedersen NL, Brismar K, de Faire U 1997 Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am J Hum Genet 60:143-152
3. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF 1991 Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77
4. Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R 2001 Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J 15:2099-2111
5. Harrap SB, Zammit KS, Wong ZY, Williams FM, Bahlo M, Tonkin AM, Anderson ST 2002 Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler Thromb Vasc Biol 22:874-878
6. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald SM, Pedersen O 1993 Amino acid polymorphism in insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 342:828-832
7. Imai Y, Fusco A, Suzuki Y, Lesniak M, D'Alfonso R, Sesti G, Bertoli A, Lauro R, Accili D, Taylor SI 1994 Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 79:1655-1658
8. Hitman GA, Hawrami K, McCarthy MI, Viswanathan M, Snehalatha C, Ramachandran A, Tuomilehto J, Tuomilehto-Wolf E, Nissinen A, Pedersen O 1995 Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease. Diabetologia 38:481-486
9. Zhang Y, Wat N, Stratton IM, Warren-Perry MG, Orho M, Groop L, Turner RC 1996 UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and β-3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. Diabetologia 39:1505-1511
10. Sigal RJ, Doria A, Warram JH, Krolewski AS 1996 Codon 972 polymorphism in the insulin receptor substrate-1 gene, obesity, and risk for noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81:1657-1659
11. Laakso M, Malkki M, Kekalainen P, Kuusisto J, Deeb S 1994 Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J Clin Invest 94:1141-1146
12. Almind K, Inoue G, Pedersen O, Kahn CR 1996 A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. J Clin Invest 97:2569-2575
13. 972 amino acid polymorphism in IRS-1 affects glucose metabolism in skeletal muscle cells. J Clin Endocrinol Metab 85:2004-2013
14. Federici M, Hribal ML, Ranalli M, Marselli L, Porzio O, Lauro D, Borboni P, Lauro R, Marchetti P, Melino G, Sesti G 2001 The common Arg972 polymorphism in insulin receptor substrate-1 causes apoptosis of human pancreatic islets. FASEB J 15:22-24
15. Baroni MG, D'andrea MP, Montali A, Pannitteri G, Barilla F, Campagna F, Mazzei E, Lovari S, Seccareccia F, Campa PP, Ricci G, Pozzilli P, Urbinati G, Arca M 1999 A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol 19: 2975-2980
16. Grant PJ, Stickland MH, Mansfield MW 1995 Insulin receptor substrate-1 gene and cardiovascular risk factors in NIDDM. Lancet 346:841-842
17. Ossei-Gerning N, Mansfield MW, Stickland MH, Grant PJ 1997 Insulin receptor substrate-1 gene polymorphism and cardiovascular risk in non-insulin dependent diabetes mellitus and patients undergoing coronary angiography Clin Lab Haematol 19:123-128
18. 972Arg in IRS-1 is not associated to lower clamp-derived insulin sensitivity in young healthy first degree relatives of patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 107:318-322
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
20. Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G, Fagot-Campagna A, Pettitt DJ, Bennett PH, Knowler WC 2000 Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 151:190-198
21. Clausen JO, Hansen T, Bjorbaek C, Echwald SM, Urhammer SA, Rasmussen S, Andersen CB, Hansen L, Almind K, Winther K, Haraldsdottir J, Borch-Johnsen K, Pedersen O 1995 Insulin resistance: interaction between obesity and a common variant of insulin receptor substrate-1. Lancet 346:397-402
22. Abe H, Yamada N, Kamata K, Kuwaki T, Shimada M, Osuga J, Shionoiri F, Yahagi N, Kadowaki T, Tamemoto H, Ishibashi S, Yazaki Y, Makuuchi M 1998 Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin-receptor substrate-1. J Clin Invest 101:1784-1788
23. Armstrong M, Haldane F, Avery PJ, Mitcheson J, Stewart MW, Turnbull DM, Walker M 1996 Relationship between insulin sensitivity and insulin receptor substrate-1 mutations in non-diabetic relatives of NIDDM families. Diabet Med 13:341-345
24. Yamada K, Yuan X, Ishiyama S, Shoji S, Kohno S, Koyama K, Koyanagi A, Koyama W, Nonaka K 1998 Codon 972 polymorphism of the insulin receptor substrate-1 gene in impaired glucose tolerance and late-onset NIDDM. Diabetes Care 21:753-756
25. Kitamura T, Kitamura Y, Kuroda S, Hino Y, Ando M, Kotani K, Konishi H, Matsuzaki H, Kikkawa U, Ogawa W, Kasuga M 1999 Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol Cell Biol 19:6286-6296
26. Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H, Quon MJ 2000 Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101:1539-1545
27. Pandolfi A, De Filippis EA, Federici M, Sesti G, Consoli A 2002 G972R IRS-1 variant impairs insulin regulation of eNOS in human endothelial cell in culture. Diabetes 51(Suppl 2):A83